Cirrhosis MRI: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The use of magnetic resonance imaging (MRI) as a diagnostic test for cirrhosis is uncertain. MRI sometimes differentiates among [[Regeneration|regenerating]] or [[Dysplasia|dysplastic]] [[Nodule (medicine)|nodules]] and [[hepatocellular carcinoma]], it is best used as a follow-up study to determine whether [[Lesion|lesions]] have changed in appearance and size.
The use of magnetic resonance imaging (MRI) as a diagnostic test for cirrhosis is uncertain. MRI differentiates [[Regeneration|regenerating]] or [[Dysplasia|dysplastic]] [[Nodule (medicine)|nodules]] and [[hepatocellular carcinoma]]. MRI is best used as a follow-up study to determine whether [[Lesion|lesions]] have changed in appearance and size. MRI may accurately diagnose cirrhosis and determines disease severity. Decreased signal intensity on MRI may also reveal an [[iron]] overload and provides an estimate of the [[Liver|hepatic]] [[iron]] concentration. [[Magnetic resonance angiography|MR angiography]] is more sensitive than [[ultrasonography]] in diagnosing complications of cirrhosis such as [[portal vein]] [[thrombosis]].


==MRI==
==MRI==
Line 10: Line 10:
* The role of magnetic resonance imaging (MRI) in the diagnosis of cirrhosis is unclear.  
* The role of magnetic resonance imaging (MRI) in the diagnosis of cirrhosis is unclear.  
* The use of MRI is limited by expense, patient intolerability, and the ability to obtain information provided by MRI through other means.  
* The use of MRI is limited by expense, patient intolerability, and the ability to obtain information provided by MRI through other means.  
* MRI differentiates among [[Regeneration|regenerating]] or [[Dysplasia|dysplastic]] [[Nodule (medicine)|nodules]] and [[hepatocellular carcinoma]] by accurately determining the nature of focal lesions.<ref name="pmid10405746" /><ref name="pmid104708852" /><ref name="pmid11584240">{{cite journal |vauthors=Choi D, Kim SH, Lim JH, Cho JM, Lee WJ, Lee SJ, Lim HK |title=Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography |journal=J Comput Assist Tomogr |volume=25 |issue=5 |pages=777–85 |year=2001 |pmid=11584240 |doi= |url=}}</ref><ref name="pmid16244259">{{cite journal |vauthors=Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV |title=Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience |journal=Radiology |volume=237 |issue=2 |pages=507–11 |year=2005 |pmid=16244259 |doi=10.1148/radiol.2372040539 |url=}}</ref>  
* MRI differentiates [[Regeneration|regenerating]] or [[Dysplasia|dysplastic]] [[Nodule (medicine)|nodules]] from [[hepatocellular carcinoma]] by accurately determining the nature of focal lesions.<ref name="pmid10405746" /><ref name="pmid104708852" /><ref name="pmid11584240">{{cite journal |vauthors=Choi D, Kim SH, Lim JH, Cho JM, Lee WJ, Lee SJ, Lim HK |title=Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography |journal=J Comput Assist Tomogr |volume=25 |issue=5 |pages=777–85 |year=2001 |pmid=11584240 |doi= |url=}}</ref><ref name="pmid16244259">{{cite journal |vauthors=Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV |title=Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience |journal=Radiology |volume=237 |issue=2 |pages=507–11 |year=2005 |pmid=16244259 |doi=10.1148/radiol.2372040539 |url=}}</ref>  
* MRI is used as a follow-up study to determine whether lesions have changed in appearance and size.  
* MRI is used as a follow-up study to determine whether lesions have changed in appearance and size.  
* MRI may accurately diagnose cirrhosis and determines disease severity.<ref name="pmid10470885">{{cite journal |author=Ito K, Mitchell DG, Hann HW, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N |title=Viral-induced cirrhosis: grading of severity using MR imaging |journal=[[AJR. American Journal of Roentgenology]] |volume=173 |issue=3 |pages=591–6 |year=1999 |month=September |pmid=10470885 |doi= |url=http://www.ajronline.org/cgi/pmidlookup?view=long&pmid=10470885 |accessdate=2012-09-06}}</ref><ref name="pmid10352597">{{cite journal |author=Ito K, Mitchell DG, Gabata T, Hussain SM |title=Expanded gallbladder fossa: simple MR imaging sign of cirrhosis |journal=[[Radiology]] |volume=211 |issue=3 |pages=723–6 |year=1999 |month=June |pmid=10352597 |doi= |url=http://radiology.rsnajnls.org/cgi/pmidlookup?view=long&pmid=10352597 |accessdate=2012-09-06}}</ref><ref name="pmid9609897">{{cite journal |author=Ito K, Mitchell DG, Hann HW, Outwater EK, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N |title=Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation |journal=[[Radiology]] |volume=207 |issue=3 |pages=729–35 |year=1998 |month=June |pmid=9609897 |doi= |url=http://radiology.rsnajnls.org/cgi/pmidlookup?view=long&pmid=9609897 |accessdate=2012-09-06}}</ref>  
* MRI may accurately diagnose cirrhosis and determines disease severity.<ref name="pmid10470885">{{cite journal |author=Ito K, Mitchell DG, Hann HW, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N |title=Viral-induced cirrhosis: grading of severity using MR imaging |journal=[[AJR. American Journal of Roentgenology]] |volume=173 |issue=3 |pages=591–6 |year=1999 |month=September |pmid=10470885 |doi= |url=http://www.ajronline.org/cgi/pmidlookup?view=long&pmid=10470885 |accessdate=2012-09-06}}</ref><ref name="pmid10352597">{{cite journal |author=Ito K, Mitchell DG, Gabata T, Hussain SM |title=Expanded gallbladder fossa: simple MR imaging sign of cirrhosis |journal=[[Radiology]] |volume=211 |issue=3 |pages=723–6 |year=1999 |month=June |pmid=10352597 |doi= |url=http://radiology.rsnajnls.org/cgi/pmidlookup?view=long&pmid=10352597 |accessdate=2012-09-06}}</ref><ref name="pmid9609897">{{cite journal |author=Ito K, Mitchell DG, Hann HW, Outwater EK, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N |title=Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation |journal=[[Radiology]] |volume=207 |issue=3 |pages=729–35 |year=1998 |month=June |pmid=9609897 |doi= |url=http://radiology.rsnajnls.org/cgi/pmidlookup?view=long&pmid=9609897 |accessdate=2012-09-06}}</ref>  

Revision as of 18:46, 13 December 2017

Cirrhosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cirrhosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Cirrhosis MRI On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cirrhosis MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cirrhosis MRI

CDC on Cirrhosis MRI

Cirrhosis MRI in the news

Blogs on Cirrhosis MRI

Directions to Hospitals Treating Cirrhosis

Risk calculators and risk factors for Cirrhosis MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vishnu Vardhan Serla M.B.B.S. [2]

Overview

The use of magnetic resonance imaging (MRI) as a diagnostic test for cirrhosis is uncertain. MRI differentiates regenerating or dysplastic nodules and hepatocellular carcinoma. MRI is best used as a follow-up study to determine whether lesions have changed in appearance and size. MRI may accurately diagnose cirrhosis and determines disease severity. Decreased signal intensity on MRI may also reveal an iron overload and provides an estimate of the hepatic iron concentration. MR angiography is more sensitive than ultrasonography in diagnosing complications of cirrhosis such as portal vein thrombosis.

MRI

Role of MRI in cirrhosis:[1][2][3][4][5][6][7]

  • The role of magnetic resonance imaging (MRI) in the diagnosis of cirrhosis is unclear.
  • The use of MRI is limited by expense, patient intolerability, and the ability to obtain information provided by MRI through other means.
  • MRI differentiates regenerating or dysplastic nodules from hepatocellular carcinoma by accurately determining the nature of focal lesions.[1][2][8][9]
  • MRI is used as a follow-up study to determine whether lesions have changed in appearance and size.
  • MRI may accurately diagnose cirrhosis and determines disease severity.[10][11][12]
  • Decreased signal intensity on MRI may also reveal an iron overload and provides an estimate of the hepatic iron concentration.

MRA

  • The use of MRA is limited by its expense and the ability of routine ultrasonography with Doppler to obtain adequate information for the diagnosis of cirrhosis and presence of complications.
  • T2

    T2

  • T2

    T2

References

  1. ↑ 1.0 1.1 Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Rijcken TH, Stark DD (1999). "Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques". Radiology. 212 (1): 227–34. doi:10.1148/radiology.212.1.r99jl35227. PMID 10405746.
  2. ↑ 2.0 2.1 Ito K, Mitchell DG, Hann HW, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N (1999). "Viral-induced cirrhosis: grading of severity using MR imaging". AJR Am J Roentgenol. 173 (3): 591–6. doi:10.2214/ajr.173.3.10470885. PMID 10470885.
  3. ↑ Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris JC, L'Herminé C (1997). "Hepatic iron overload: diagnosis and quantification with MR imaging". AJR Am J Roentgenol. 168 (5): 1205–8. doi:10.2214/ajr.168.5.9129412. PMID 9129412.
  4. ↑ Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhé T, Brissot P, Carsin M, Deugnier Y (1994). "Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging". Radiology. 193 (2): 533–8. doi:10.1148/radiology.193.2.7972774. PMID 7972774.
  5. ↑ Ito K, Mitchell DG, Gabata T, Hussain SM (1999). "Expanded gallbladder fossa: simple MR imaging sign of cirrhosis". Radiology. 211 (3): 723–6. doi:10.1148/radiology.211.3.r99ma31723. PMID 10352597.
  6. ↑ Ito K, Mitchell DG, Hann HW, Outwater EK, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N (1998). "Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation". Radiology. 207 (3): 729–35. doi:10.1148/radiology.207.3.9609897. PMID 9609897.
  7. ↑ Finn JP, Kane RA, Edelman RR, Jenkins RL, Lewis WD, Muller M, Longmaid HE (1993). "Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography". AJR Am J Roentgenol. 161 (5): 989–94. doi:10.2214/ajr.161.5.8273643. PMID 8273643.
  8. ↑ Choi D, Kim SH, Lim JH, Cho JM, Lee WJ, Lee SJ, Lim HK (2001). "Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography". J Comput Assist Tomogr. 25 (5): 777–85. PMID 11584240.
  9. ↑ Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV (2005). "Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience". Radiology. 237 (2): 507–11. doi:10.1148/radiol.2372040539. PMID 16244259.
  10. ↑ Ito K, Mitchell DG, Hann HW, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N (1999). "Viral-induced cirrhosis: grading of severity using MR imaging". AJR. American Journal of Roentgenology. 173 (3): 591–6. PMID 10470885. Retrieved 2012-09-06. Unknown parameter |month= ignored (help)
  11. ↑ Ito K, Mitchell DG, Gabata T, Hussain SM (1999). "Expanded gallbladder fossa: simple MR imaging sign of cirrhosis". Radiology. 211 (3): 723–6. PMID 10352597. Retrieved 2012-09-06. Unknown parameter |month= ignored (help)
  12. ↑ Ito K, Mitchell DG, Hann HW, Outwater EK, Kim Y, Fujita T, Okazaki H, Honjo K, Matsunaga N (1998). "Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation". Radiology. 207 (3): 729–35. PMID 9609897. Retrieved 2012-09-06. Unknown parameter |month= ignored (help)
  13. ↑ Finn JP, Kane RA, Edelman RR, Jenkins RL, Lewis WD, Muller M, Longmaid HE (1993). "Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography". AJR. American Journal of Roentgenology. 161 (5): 989–94. PMID 8273643. Retrieved 2012-09-06. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Cirrhosis_MRI&oldid=1405761"